Summit Therapeutics Ratios (2017-2026) | SMMT

Ratios Jan2017 Apr2017 Jul2017 Oct2017 Jan2018 Apr2018 Jul2018 Oct2018 Jan2019 Mar2019 Jul2019 Sep2019 Oct2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Profitability
Gross Margin (Quarter)
EBT Margin (Quarter)
-1,497.25%-10,796.41%-8,982.00%-5,678.72%-8,014.55%
EBIT Margin (Quarter)
-1,488.62%-10,377.29%-8,863.20%-5,400.85%-7,700.00%
EBITDA Margin (Quarter)
-1,488.62%-10,377.29%-8,863.20%-5,400.85%-7,700.00%
Operating Margin (Quarter)
-1,488.62%-10,377.29%-8,863.20%-5,400.85%-7,700.00%
Net Margin (Quarter)
-1,497.25%-10,796.41%-8,982.00%-5,678.72%-8,014.55%
FCF Margin (Quarter)
-1,799.92%-3,704.78%-7,744.80%-8,302.13%-3,879.55%
Efficiency
Assets Average (Quarter)
137.09M121.02M114.92M106.09M125.52M409.75M459.53M246.13M227.92M210.71M189.87M259.32M422.35M469.21M409.69M353.93M292.88M506.46M699.52M700.02M
Invested Capital (Quarter)
Asset Utilization Ratio (Quarter)
0.010.010.020.020.010.000.000.00
Leverage & Solvency
Interest Coverage Ratio (Quarter)
-32.68-74.61-19.44-24.48-6.99-64.51-4.53-7.03-12.50-13.58-19.22-23.78-8.98
Debt Ratio (Quarter)
0.220.260.740.390.420.490.57
Times Interest Earned (Quarter)
-32.68-74.61-19.44-24.48-6.99-64.51-4.53-7.03-12.50-13.58-19.22-23.78-8.98
Valuation
Enterprise Value (Quarter)
-71.79M-121.97M-648.61M-241.93M-215.01M-198.94M-71.42M-61.61M-28.75M-94.10M-412.35M-211.84M-298.19M-238.88M-713.45M-598.73M-690.68M
Return Ratios
Return on Sales (Quarter)
-0.15%-1.08%-0.90%-0.57%-0.80%-1.09%-13.16%-27.48%
Return on Capital Employed (Quarter)
-62.72%-90.34%-99.16%-88.41%-71.51%-19.43%-132.80%-252.00%-519.99%-320.35%-69.03%-133.20%-54.11%-52.87%
Return on Invested Capital (Quarter)
Return on Assets (Quarter)
-0.01%-0.01%-0.01%-0.01%-0.01%0.00%-0.01%-0.02%-0.03%-0.03%-0.01%-0.01%0.00%-0.01%0.00%0.00%0.00%